Changes in plasma hormones and heart rate variability in patients receiving the cardiotoxic anti-cancer agent bevacizumab.
Int J Cardiol
; 219: 25-6, 2016 Sep 15.
Article
in En
| MEDLINE
| ID: mdl-27257852
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Aldosterone
/
Cardiotoxins
/
Bevacizumab
/
Heart Rate
/
Antineoplastic Agents
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Int J Cardiol
Year:
2016
Document type:
Article
Affiliation country:
Canada
Country of publication:
Netherlands